Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
NEW YORK (Reuters Health) – Adding midazolam to ketamine for emergency department sedation in adults reduces the occurrence of agitation during recovery, investigators report in the Annals of…
NEW YORK (Reuters Health) – Rosuvastatin halves the rate of primary cardiovascular events in patients who have a high global cardiovascular risk profile, according to a post hoc…
NEW YORK (Reuters Health) – In patients hospitalized for infection, continuing pre-existing statin therapy does not improve outcomes, and discontinuing the therapy does not lead to an inflammatory…
NEW YORK (Reuters Health) – The common practice of routinely testing patients with ischemic stroke for inherited thrombophilias can do more harm than good, according to a new…
NEW YORK (Reuters Health) – About 1% of outpatient endoscopies require a subsequent visit to the emergency room for related complications, but fewer than a quarter of these…
NEW YORK (Reuters Health) – In order to minimize the risk of potential harms, erythropoiesis-stimulating agents (ESAs) in patients undergoing myelosuppressive chemotherapy should be administered at the lowest…
NEW YORK (Reuters Health) – The reported sensitivity of numerous blood-based markers proposed for the early detection of colorectal cancer (CRC) are probably higher than might be expected…
The first annual Mobile Health Expo was held on October 19-21, 2010 in Las Vegas, NV. The conference was attended by leaders in areas including mobile medicine, wireless…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
